→
Albemarle Corp's current price stands at $180.38, down 5.61% from the previous close of $191.1, reflecting ongoing volatility. With a market cap of $21.27B and a revenue growth rate of 7.87% YoY, the company's fundamentals show some promise, despite a negative ROE of -2.35%. Analysts remain cautiously optimistic, with 6 Strong Buy ratings, indicating potential for recovery.
Investors should hold their positions in Albemarle Corp while monitoring for further signs of improvement in operational metrics.
If Albemarle can capitalize on its 7.87% revenue growth and improve its ROE, the stock could recover towards its 52-week high of $221, representing an upside of approximately 22.5%. Additionally, the strong analyst consensus with 16 Buy ratings suggests that institutional investors are optimistic about the company's future prospects.
However, the recent earnings miss in Q4 2025, where actual earnings were -$0.53 compared to an estimate of -$0.41, raises concerns about operational efficiency. Coupled with a high beta of 1.38, the stock may experience increased volatility, posing risks for investors in a turbulent market environment.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Helm's AI rates ALB as Neutral. Investors should hold their positions in Albemarle Corp while monitoring for further signs of improvement in operational metrics.
However, the recent earnings miss in Q4 2025, where actual earnings were -$0.53 compared to an estimate of -$0.41, raises concerns about operational efficiency. Coupled with a high beta of 1.38, the stock may experience increased volatility, posing risks for investors in a turbulent market environment.
If Albemarle can capitalize on its 7.87% revenue growth and improve its ROE, the stock could recover towards its 52-week high of $221, representing an upside of approximately 22.5%. Additionally, the strong analyst consensus with 16 Buy ratings suggests that institutional investors are optimistic about the company's future prospects.
Albemarle Corp's current price stands at $180.38, down 5.61% from the previous close of $191.1, reflecting ongoing volatility. With a market cap of $21.27B and a revenue growth rate of 7.87% YoY, the company's fundamentals show some promise, despite a negative ROE of -2.35%. Analysts remain cautiously optimistic, with 6 Strong Buy ratings, indicating potential for recovery.
Albemarle Corp's current price stands at $180.38, down 5.61% from the previous close of $191.1, reflecting ongoing volatility. With a market cap of $21.27B and a revenue growth rate of 7.87% YoY, the company's fundamentals show some promise, despite a negative ROE of -2.35%. Analysts remain cautiously optimistic, with 6 Strong Buy ratings, indicating potential for recovery. Our overall verdict is Neutral.
Helm Terminal offers free AI-powered stock analysis for ALB at helmterminal.dev/analyze/ALB, updated continuously during US market hours. No signup required.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.